Targeting Cystalysin, a Virulence Factor of Treponema denticola‐Supported Periodontitis
暂无分享,去创建一个
Pietro Cozzini | Glen E Kellogg | Francesca Spyrakis | Paolo Benedetti | Gabriele Cruciani | Emanuele Carosati | Andrea Mozzarelli | Stefano Bruno | F. Spyrakis | G. Cruciani | A. Mozzarelli | G. Kellogg | P. Cozzini | E. Carosati | S. Bruno | C. Voltattorni | B. Cellini | Paolo Benedetti | Barbara Cellini | Fabrizio Micheli | Antonio Felici | Carla Borri Voltattorni | F. Micheli | A. Felici | Glen E. Kellogg
[1] Francesco Bossa,et al. Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors , 2012, PloS one.
[2] Gabriele Cruciani,et al. A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application , 2007, J. Chem. Inf. Model..
[3] Giorgio Palù,et al. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase , 2012, Proceedings of the National Academy of Sciences.
[4] Pietro Cozzini,et al. Unintended consequences? Water molecules at biological and crystallographic protein-protein interfaces , 2013, Comput. Biol. Chem..
[5] Anna Marabotti,et al. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water. , 2002, Journal of medicinal chemistry.
[6] M. Bertoldi,et al. Treponema denticola cystalysin catalyzes β‐desulfination of L‐cysteine sulfinic acid and β‐decarboxylation of L‐aspartate and oxalacetate , 2003 .
[7] Loriano Storchi,et al. In silico pKa Prediction and ADME Profiling , 2009, Chemistry & biodiversity.
[8] Kate S Carroll,et al. Drug targets in mycobacterial sulfur metabolism. , 2007, Infectious disorders drug targets.
[9] A. Mozzarelli,et al. Protein crystal microspectrophotometry. , 2011, Biochimica et biophysica acta.
[10] F. Bossa,et al. In silico and in vitro validation of serine hydroxymethyltransferase as a chemotherapeutic target of the antifolate drug pemetrexed. , 2011, European journal of medicinal chemistry.
[11] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[12] Manfred Kansy,et al. Extending pKa prediction accuracy: high-throughput pKa measurements to understand pKa modulation of new chemical series. , 2010, European journal of medicinal chemistry.
[13] G. Cruciani,et al. Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field. , 2004, Journal of medicinal chemistry.
[14] S. Holt,et al. Hemoxidation and binding of the 46-kDa cystalysin of Treponema denticola leads to a cysteine-dependent hemolysis of human erythrocytes. , 1999, Oral microbiology and immunology.
[15] G. Kurzban,et al. Sulfhemoglobin formation in human erythrocytes by cystalysin, an L-cysteine desulfhydrase from Treponema denticola. , 1999, Oral microbiology and immunology.
[16] A. Mozzarelli,et al. Catalytic competence of O-acetylserine sulfhydrylase in the crystal probed by polarized absorption microspectrophotometry. , 1998, Journal of molecular biology.
[17] Stefano Sabatini,et al. Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. , 2011, Journal of medicinal chemistry.
[18] M. Surette,et al. Cysteine biosynthesis, oxidative stress and antibiotic resistance in Salmonella typhimurium. , 2010, Research in microbiology.
[19] M. Bertoldi,et al. Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies. , 2005, Biochemistry.
[20] Z. Dong,et al. Hydrogen sulfide induces apoptosis in human periodontium cells. , 2010, Journal of periodontal research.
[21] A. Mozzarelli,et al. Design and synthesis of trans-2-substituted-cyclopropane-1-carboxylic acids as the first non-natural small molecule inhibitors of O-acetylserine sulfhydrylase , 2012 .
[22] Pietro Cozzini,et al. Mapping the energetics of water-protein and water-ligand interactions with the "natural" HINT forcefield: predictive tools for characterizing the roles of water in biomolecules. , 2006, Journal of molecular biology.
[23] G. Bricogne,et al. Trapping of the Thioacylglyceraldehyde-3-phosphate Dehydrogenase Intermediate from Bacillus stearothermophilus , 2008, Journal of Biological Chemistry.
[24] Anna Marabotti,et al. Energetics of the protein-DNA-water interaction , 2007, BMC Structural Biology.
[25] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[26] T. Clausen,et al. Crystal structure of cystalysin from Treponema denticola: a pyridoxal 5′‐phosphate‐dependent protein acting as a haemolytic enzyme , 2000, The EMBO journal.
[27] Stefano Alcaro,et al. GRID-Based Three-Dimensional Pharmacophores II: PharmBench, a Benchmark Data Set for Evaluating Pharmacophore Elucidation Methods , 2012, J. Chem. Inf. Model..
[28] G. Kurzban,et al. Cystalysin, a 46-kilodalton cysteine desulfhydrase from Treponema denticola, with hemolytic and hemoxidative activities , 1997, Infection and immunity.
[29] Glen Eugene Kellogg,et al. Very empirical treatment of solvation and entropy: a force field derived from Log Po/w , 2001, J. Comput. Aided Mol. Des..
[30] A. Mozzarelli,et al. Crystals of Tryptophan Indole-Lyase and Tyrosine Phenol-Lyase Form Stable Quinonoid Complexes* , 2002, The Journal of Biological Chemistry.
[31] Pietro Cozzini,et al. Computational titration analysis of a multiprotic HIV-1 protease-ligand complex. , 2004, Journal of the American Chemical Society.
[32] A. Mozzarelli,et al. Functional Properties of the Active Core of Human Cystathionine β-Synthase Crystals* , 2001, The Journal of Biological Chemistry.
[33] Hugo Gutiérrez-de-Terán,et al. Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A1, A2A, A2B, and A3 receptor antagonists , 2012, Journal of Computer-Aided Molecular Design.
[34] A. Mozzarelli,et al. Protein function in the crystal. , 1996, Annual review of biophysics and biomolecular structure.
[35] A. Mozzarelli,et al. Microspectrophotometry for structural enzymology. , 2004, Current opinion in structural biology.
[36] Maria Paola Costi,et al. Inhibitor of ovarian cancer cells growth by virtual screening: a new thiazole derivative targeting human thymidylate synthase. , 2012, Journal of medicinal chemistry.
[37] R. Huber,et al. Snapshots of the Cystine Lyase C-DES during Catalysis , 2003, The Journal of Biological Chemistry.
[38] D. Laurents,et al. Holo- and apo-cystalysin from Treponema denticola: two different conformations. , 2006, Archives of biochemistry and biophysics.
[39] M. Bertoldi,et al. Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin. , 2002, Biochemistry.
[40] L. Goracci,et al. Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses , 2012, Antimicrobial Agents and Chemotherapy.
[41] N. Grishin,et al. Modeling of the spatial structure of eukaryotic ornithine decarboxylases , 1995, Protein science : a publication of the Protein Society.
[42] A. Paiardini,et al. Site-directed Mutagenesis Provides Insight into Racemization and Transamination of Alanine Catalyzed by Treponema denticola Cystalysin* , 2004, Journal of Biological Chemistry.
[43] Loriano Storchi,et al. New and Original pKa Prediction Method Using Grid Molecular Interaction Fields , 2007, J. Chem. Inf. Model..
[44] Pietro Cozzini,et al. Bound Water at Protein-Protein Interfaces: Partners, Roles and Hydrophobic Bubbles as a Conserved Motif , 2011, PloS one.
[45] F. Spyrakis,et al. The consequences of scoring docked ligand conformations using free energy correlations. , 2007, European journal of medicinal chemistry.
[46] R. Glen,et al. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.
[47] B. Cosimelli,et al. Calcium channel antagonists discovered by a multidisciplinary approach. , 2006, Journal of medicinal chemistry.
[48] Pietro Cozzini,et al. Fine tuning of the active site modulates specificity in the interaction of O-acetylserine sulfhydrylase isozymes with serine acetyltransferase. , 2013, Biochimica et biophysica acta.
[49] A. Mozzarelli,et al. X-ray crystallography marries spectroscopy to unveil structure and function of biological macromolecules. , 2011, Biochimica et biophysica acta.
[50] A. Paiardini,et al. Treponema denticola cystalysin exhibits significant alanine racemase activity accompanied by transamination: mechanistic implications. , 2003, The Biochemical journal.
[51] Michael D Shultz,et al. Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters. , 2013, Bioorganic & medicinal chemistry letters.
[52] Pietro Cozzini,et al. Isozyme-Specific Ligands for O-acetylserine sulfhydrylase, a Novel Antibiotic Target , 2013, PloS one.
[53] S. Bembenek,et al. Ligand binding efficiency: trends, physical basis, and implications. , 2008, Journal of medicinal chemistry.
[54] M. Bertoldi,et al. Lysine 238 Is an Essential Residue for α,β-Elimination Catalyzed by Treponema denticola Cystalysin* , 2003, Journal of Biological Chemistry.
[55] Pietro Cozzini,et al. Robust classification of "relevant" water molecules in putative protein binding sites. , 2008, Journal of medicinal chemistry.
[56] Alexander S. Bayden,et al. Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature. , 2010, Journal of medicinal chemistry.
[57] Paola Storici,et al. Structures of γ-Aminobutyric Acid (GABA) Aminotransferase, a Pyridoxal 5′-Phosphate, and [2Fe-2S] Cluster-containing Enzyme, Complexed with γ-Ethynyl-GABA and with the Antiepilepsy Drug Vigabatrin* , 2003, Journal of Biological Chemistry.
[58] Alessio Amadasi,et al. Pyridoxal 5'-phosphate enzymes as targets for therapeutic agents. , 2007, Current medicinal chemistry.